NIGHTINGALE HEALTH EO 1 (7XE) - Total Liabilities
Based on the latest financial reports, NIGHTINGALE HEALTH EO 1 (7XE) has total liabilities worth €9.06 Million EUR (≈ $10.59 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
NIGHTINGALE HEALTH EO 1 - Total Liabilities Trend (2022–2025)
This chart illustrates how NIGHTINGALE HEALTH EO 1's total liabilities have evolved over time, based on quarterly financial data. See NIGHTINGALE HEALTH EO 1 working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
NIGHTINGALE HEALTH EO 1 Competitors by Total Liabilities
The table below lists competitors of NIGHTINGALE HEALTH EO 1 ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
TDb Split Corp
TO:XTD
|
Canada | CA$47.56 Million |
|
Beamtree Holdings Ltd
AU:BMT
|
Australia | AU$13.76 Million |
|
Aquirian Ltd
AU:AQN
|
Australia | AU$21.75 Million |
|
ORTOMA AB B
F:82Y
|
Germany | €18.63 Million |
|
Citigold Corporation Ltd
AU:CTO
|
Australia | AU$21.77 Million |
|
SK Chemicals Co Ltd Pref
KO:28513K
|
Korea | ₩2.60 Trillion |
|
Alpha Trust Andromeda Investment Trust S.A
AT:ANDRO
|
Greece | €2.26 Million |
|
Elcomtec Co. Ltd
KQ:037950
|
Korea | ₩12.73 Billion |
Liability Composition Analysis (2022–2025)
This chart breaks down NIGHTINGALE HEALTH EO 1's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of NIGHTINGALE HEALTH EO 1.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 8.53 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.16 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.14 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how NIGHTINGALE HEALTH EO 1's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for NIGHTINGALE HEALTH EO 1 (2022–2025)
The table below shows the annual total liabilities of NIGHTINGALE HEALTH EO 1 from 2022 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | €8.35 Million ≈ $9.76 Million |
+4.87% |
| 2024-06-30 | €7.96 Million ≈ $9.30 Million |
-15.66% |
| 2023-06-30 | €9.44 Million ≈ $11.03 Million |
-25.15% |
| 2022-06-30 | €12.61 Million ≈ $14.74 Million |
-- |
About NIGHTINGALE HEALTH EO 1
Nightingale Health Oyj, a health technology company, offers advanced health check that detects disease risks in Finland, the United Kingdom, rest of Europe, the United States, and internationally. The company's Health Check that detects the risks associated with various common chronic diseases from a single blood sample; and Remote Health Check where health check done remotely. It also offers blo… Read more